Nureca share price

Date Open High Low Close Volume 15/06/2023 371.80 376.00 362.50 365.25 22586 14/06/2023 380.00 384.40 370.00 372.85 23614 13/06/2023 379.80 385.00 376.00 378.60 14307 12/06/2023 380.10 386.00 374.00 376.50 25684 09/06/2023 399.00 399.00 384.00 385.05 19150 08/06/2023 400.00 408.85 389.65 391.35 51645 07/06/2023 392.70 423.50 392.05 410.15 593448 06/06/2023 408.00 408.90 384.05 388.45 265484 05/06/2023 417.70 427.95 407.45 410.85 686652 02/06/2023 405.95 443.90 401.05 423.55 5610862 01/06/2023 316.00 378.70 316.00 378.70 1298735 31/05/2023 316.50 317.70 314.15 315.60 24407 30/05/2023 317.00 319.45 313.00 314.05 27321 29/05/2023 323.95 323.95 315.10 316.90 26818 26/05/2023 316.50 324.00 316.50 318.35 26112 25/05/2023 324.95 324.95 313.65 315.50 51301 24/05/2023 319.05 323.70 311.05 317.60 56262 23/05/2023 328.00 337.35 325.00 327.20 66008 22/05/2023 323.20 329.55 323.20 326.15 20193 19/05/2023 329.90 330.00 325.00 327.50 20268 18/05/2023 332.70 334.65 323.30 327.60 27511 17/05/2023 332.00 334.20 329.25 330.25 28243 Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd. BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.

Americas+1 212 318 2000 EMEA+44 20 7330 7500 Asia Pacific+65 6212 1000 • Company • • • • • • • • • Communications • • Follow • • • • • • Products • • • • • Industry Products • • • • • Media • • • • • • • • • • Media Services • • • Company • • • • • • • • • Communications • • Follow • • • • • • Products • • • • • Industry Products • • • • • • Media • • Technology • • • • Businessweek • • • • Media Services • • • Bloomberg Nureca Limited provides home healthcare and wellness products. The Company offers products through online channel partners such as e-commerce players, distributors, and retailers which enables users to monitor chronic ailments and other diseases. Nureca serves customers in India and the United States.

Sector Healthcare Compare with Sector peers Industry Medical Equipment/Supplies/Accessories Compare with Industry peers Website http://www.nureca.com Market Cap 364.16 Cr. Enterprise Value(EV) 293.12 Cr. 2023-03 Financial Indicators • Consolidated • Standalone Earnings per share (EPS) -8.25 Trailing Twelve Months Ending 2023-03 Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03 Industry PE 60.75 Trailing Twelve Months Ending 2023-03 Book Value / Share 194.88 Trailing Twelve Months Ending 2023-03 Price to Book Value 1.87 Calculated using Price: 364.00 Dividend Yield 0.82 Period Ending 2022-03 No. of Shares Subscribed 1.00 Cr. 10,000,175 Shares FaceValue 10 About Nureca Ltd. Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr. Shh. Funds 2 8 15 163 203 195 Non Curr. Liab. 0 0 9 3 4 0 Curr. Liab. 5 15 10 24 45 9 Minority Int. Equity & Liab. 7 24 34 190 252 204 Non Curr. Assets 0 1 1 4 13 17 Curr...

• The company has shown a good revenue growth of 605.1050221719% for the Past 3 years. • Company has been maintaining healthy ROE of 56.2226972739797% over the past 3 years. • Company has been maintaining healthy ROCE of 59.1156199712149% over the past 3 years. • Company is virtually debt free. • Company has a healthy Interest coverage ratio of 84.8987688098495. • The company has an efficient Cash Conversion Cycle of 51.0841295425456 days. • Company has a healthy liquidity position with current ratio of 5.29006669473311. • The company has a high promoter holding of 62.98%. Quarterly Result (All Figures in Cr.) PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Net Sales 41.08 26.06 36.79 27.84 21.22 Total Expenditure 43.61 31.55 41.63 29.08 25.03 Operating Profit -2.53 -5.49 -4.84 -1.24 -3.81 Other Income 1.71 1.18 1.91 1.92 2.15 Interest 0.28 0.13 0.1 0.1 0.1 Depreciation 0.57 0.59 0.6 0.58 0.54 Exceptional Items 0 0 0 0 0 Profit Before Tax -1.67 -5.04 -3.63 0.01 -2.3 Tax -0.5 -1.17 -0.84 -0.02 -0.5 Profit After Tax -1.17 -3.87 -2.78 0.03 -1.8 Adjusted EPS (Rs) -1.17 -3.87 -2.78 0.03 -1.8 Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.) PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Net Sales 0.59 0.73 99.43 213.33 255.55 Total Expenditure 0.56 0.7 89.72 151.65 199.78 Operating Profit 0.02 0.03 9.71 61.68 55.77 Other Income 0 0 0.06 2.82 7.72 Interest 0 0 0.77 1.6 0.73 Depreciation 0 0 0.37 0.41 1.43 Exceptional Items 0 0 0 0 0 Profit Before Tax 0.02...

Nureca Limited is an India-based company, which is engaged in the business of home healthcare and wellness products. The main products/services that the Company manufactures include chronic disease products, orthopedic products, mother and child products, nutrition supplements and lifestyle products. Its chronic disease products include connected products, nebulizers, BP monitors, finger pulse oximeters, glucose meters and thermometers. Its orthopedic products include massagers, pain monitors, posture correctors and rehabilitation products. Its mother and babycare products include baby feeding, carry cots, baby skincare, nebulizers and bottle warmers and steamers. Its nutrition supplements include supplements and weight management products. Its lifestyle products include humidifiers and steamers, personal scales, massagers, yoga and exercise, fitness tracking, and dental and personal care. The Company's products are offered through its brands, such as Dr Trust, Dr Physio, and Trumom.; Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you. 2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with y...

Shares of Nureca Ltd hit an all-time low today after Payal Goyal, a promoter of the firm, sold a part of her stake via bulk deal on November 28. Nureca stock hit a fresh low of Rs 525, down 2.48% against the previous close of Rs 538.35 on BSE. The stock opened lower at Rs 536 on BSE. The stock has lost 17.69% in the last 6 days. The microcap stock also touched an intraday high of Rs 563.45, rising 4.66% on BSE. In a year, the stock has lost 64.16% and fallen 73.57 per cent this year. Total 0.39 lakh shares of the firm changed hands amounting to a turnover of Rs 2.07 crore on BSE. In a month, the stock has fallen 32.18%. Five promoters held 70% stake or 69.99 lakh shares of the firm at the end of Q2. On the other hand, public shareholders held 30% stake or 3 lakh shares at the end of September quarter. Also Read: The firm reported a loss of Rs 2.89 crore in Q2 against a profit of Rs 5.43 crore in the September quarter of the previous fiscal. Sales slipped 21.64% to Rs 36.78 crore in the last quarter against Rs 46.94 crore in Q2 of previous fiscal. EBITDA for Q2 stood at Rs 3 crore (loss). In the first half of this fiscal, operating revenue stood at Rs 62.3 crore as compared to Rs 1,66.4 crore in H1’FY22, falling 63%. Overall, demand fell in H1’FY23 as compared to the same period last year, which had seen a huge surge in demand due to Covid-19. Nureca is engaged in the business of home healthcare and wellness products. The main products/services that the company manufactures...